Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation

Cancer Gene Therapy

Volumn 18, Issue 9, 2011, Pages 609-616

  Yang, Z ^a   Zhang, X Q ^a   Dinney, C N P ^a   Benedict, W F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

adenoviral mediated interferon ; caspase 4 activation; ER stress

Indexed keywords

ADENOVIRUS VECTOR; ALPHA2B INTERFERON; CASPASE 4;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER RESISTANCE; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INHIBITION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA INTERFERENCE;

ADENOVIRIDAE; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASES, INITIATOR; ENDOPLASMIC RETICULUM STRESS; GENETIC VECTORS; HELA CELLS; HUMANS; IMMUNOCHEMISTRY; INTERFERON-ALPHA; MICROSCOPY, CONFOCAL; RNA INTERFERENCE;

EID: 80052037476     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.26     Document Type: Article

References (11)

1. Benedict WF, Tao Z, Kim CS, Zhang X, Zhou JH, Adam L et al. Intravesical Ad-IFN alpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcome resistance to IFN-alpha protein. Mol Ther 2004; 10: 525-532. (Pubitemid 39186113)
2. Tao Z, Connor RJ, Ashoori F, Dinney CP, Munsell M, Philopena JA et al. Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation. Cancer Gene Ther 2006; 13: 125-130. (Pubitemid 43113413)
3. Zhang X-Q, Yang Z, Dong L, Papageorgiou A, McConkey D, Benedict WF. Adenoviral-mediated interferon a overcomes resistance to the interferon protein in various cancer types and has marked bystander effects. Cancer Gene Ther 2007; 14: 241-250.
4. Zhang X, Dong L, Chapman E, Benedict WF. Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect. Cancer Gene Ther 2008; 12: 817-822.
5. Papageorgiou A, Lashinger L, Millikan R, Benedict WF, Dinney CP, McConkey DJ. Autocrine TRAIL production mediates interferon-induced apoptosis in human bladder cancer cells. Cancer Res 2004; 64: 8973-8979. (Pubitemid 39665506)
6. Benedict WF, Fisher MB, Cutler DL, Young AA, Yang Z, O'Donnell MA et al. Results of a Phase 1 trial with intravesical Ad-IFN-a/Syn3 for superficial bladder cancer including putative marker studies (abstract). In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research 2009, Abstract #1449.
7. Fisher MB, Zhang XQ, McConkey DJ, Benedict WF. Measuring soluble forms of extracellular cytokeratin18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker. Cancer Gene Ther 2009; 16: 567-572.
8. Watanabe T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T et al. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 2000; 7: 1575-1580. (Pubitemid 32098768)
9. Chapman EJ, Hurst CD, Pitt E, Chambers P, Aveyard JS, Knowles MA. Expression of hTERT immortalizes normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene 2006; 25: 5037-5045.
10. Zhang XQ, Yang Z, Benedict WF. Direct gene transfer of adenoviral-mediated interferon a into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity. Cancer Gene Ther 2011; 18: 260-264.
11. Zhang XQ, Dunner K, Benedict WF. Autophagy is induced by adenoviral-mediated interferon a treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced. Cancer Gene Ther 2010; 8: 579-584.